People · Operator

James R. Baumgardt

Named in public records as an officer, director or promoter · active 2008–2016 · Other Health Care

1
Companies
4
Filings
$58.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NICO CorpOther Health CareSeries B$58.7M$143.0M2008
Operator network

James R. Baumgardt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Carter McNabb · 10 companies · 1 sharedCarter McNabbNiles L. Noblitt · 3 companies · 1 sharedNiles L. NoblittJ. Carter McNabb · 2 companies · 1 sharedJ. Carter McNabbJeffrey L. Hanthorn · 2 companies · 1 sharedJeffrey L. Hantho…Joseph L. Mark · 2 companies · 1 sharedJoseph L. MarkKeith E. Brauer · 2 companies · 1 sharedKeith E. BrauerMARK ROSENBLUM · 2 companies · 1 sharedMARK ROSENBLUMDr. Mark L. Rosenblum · 1 companies · 1 sharedDr. Mark L. Rosen…Eric L. Timko · 1 companies · 1 sharedEric L. TimkoJeffrey Hanthorn · 1 companies · 1 sharedJeffrey HanthornJim Pearson · 1 companies · 1 sharedJim PearsonJoe Mark · 1 companies · 1 sharedJoe MarkJoseph Mark · 1 companies · 1 sharedJoseph MarkThomas L. Tefft · 1 companies · 1 sharedThomas L. TefftNICO Corp · $58.7M raisedNICO CorpJames R. BaumgardtJB
James R. Baumgardt Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside James R. Baumgardt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Carter McNabb110
Niles L. Noblitt13
Joseph L. Mark12
J. Carter McNabb12
Keith E. Brauer12
Jeffrey L. Hanthorn12
MARK ROSENBLUM12
Joseph Mark11
Eric L. Timko11
Dr. Mark L. Rosenblum11
Joe Mark11
Jeffrey Hanthorn11
Jim Pearson11
Thomas L. Tefft11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.